|
CGTX Cognition Therapeutics Inc 1455365 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-4,570,000.00 |
| Balance Sheet |
|
Current Assets
|
$35,814,000.00 |
|
Assets
|
$36,140,000.00 |
|
Current Liabilities
|
$6,053,000.00 |
|
Liabilities
|
$6,229,000.00 |
|
Equity
|
$29,911,000.00 |
|
Shares Out
|
89353773.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,542,000.00 |
|
Investing Cash Flow
|
$9,000.00 |
| Market Analysis |
Market Cap
|
$82,205,471.16 |
|
Price
|
$0.92 |
|
BVPS
|
0.33 |
|
PB
|
2.79 |
|
EPS
|
-0.05 |
|
FCF
|
$-5,546,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:35 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.11 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CGTX documents filed with the SEC.
CGTX Filings
Clear
